Speaker Profile

Ph.D., Senior Vice President, UMPC

Dr. Kleinz joined UPMC Enterprises in July 2017 to help the ITTC invest and commercialize innovative translational science by defining the true potential of new life science technologies, exploring optimal business models and strategies, and helping to form companies with a clear path to success. Prior to UPMC Enterprises, Dr. Kleinz spent nine years in management consulting at L.E.K. Consulting in its life sciences practice in Boston and London leading teams on over 70 strategic assignments for clients in the U.S., Europe, and Japan. Dr. Kleinz completed his PhD in the Clinical Pharmacology Unit of the University of Cambridge (UK), working on early stage discovery of G-protein-coupled receptor targets for hypertension, heart disease and metabolic syndrome and graduated from Justus Liebig University in Giessen (GER) with a doctorate in clinical veterinary medicine.

 Session Abstract – PMWC 2022 Silicon Valley

Sequencing technologies are continuously improving, making it easier to obtain more in-depth molecular information than ever before. Emerging single-cell multi-omics sequencing technologies allow the capture of multiple modalities from a cell, including its epigenome, transcriptome, epitranscriptome, and proteome. This allows research into the heterogeneity of many biological mechanisms, and insights into complex molecular mechanisms that underpin disease.


  • 4th Generation Sequencing Technologies & Genome Mapping Systems
    - Barrett Bready, Nabsys
    - Alka Chaubey, Bionano Genomics
  • Long-Read Sequencing Technologies
    - Steve Turner, PacBio
  • Single Cell Genomics
    - Michael Schnall-Levin, 10x Genomics
  • Spatial Transcriptomics
    - Jason T. Gammack, Resolve Biosciences
  • Pathogen Identification
    Session Chair: Charles Chiu, UCSF
    - Todd Dickinson, Arc Bio
    - Philip Stevens, Noscendo
  • ML/AI for Diagnosis & Prognosis
    - Amrie Grammer, Ampel BioSolutions
  • Modern Technologies for Pathogen Identification + AI
    Session Chair: Sivan Bercovici, Karius Dx
  • Proteogenomics
    - Nigel Beard, Encodia
  • Advances Proteomics - Stratifying Cardiovascular Risk to Decrease Cost of Care
    Session Chair: Roy Smythe, SomaLogic
    - Matthias Kleinz, UPMC
  • Leveraging Immune System Diagnostics to Improve Disease Outcomes
    Session Chair: Kathy Kamath, Serimmune, Inc
    - Millennia Lytle, Mymee
    - Noah Nasser, Serimmune, Inc
  • Evolving Alzheimer’s Disease Therapeutics with Neuro Diagnostic Therapies
    Session Chair: Kevin Hrusovsky, Quanterix
    - Charlotte Teunissen, Amsterdam UMC
    - Henrik Zetterberg, University of Gothenburg
    - Nicholas Ashton, University of Gothenburg
  • PMWC Showcase (NCI)
    - Michael Cardone, Eutropics Pharmaceuticals
    - Robert Meltzer, Fluent BioSciences
    - Cynthia Taylor Lawley, Olink Proteomics
    - Brian McKelligon, Akoya Biosciences